We also evaluated circulating levels of leptin and adiponectin known as markers for the diagnosis and therapy in response to saroglitazar to demonstrate its anti-inflammatory effects in the context of NASH. Here, LEP is linked to metabolic dysfunction-associated steatohepatitis.